This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
RIMA: Difference between revisions
>David Hedlund Added 5-IT |
>David Hedlund Added AMT |
||
| Line 11: | Line 11: | ||
** Turmeric (''Curcuma longa''): Curcumin<ref>{{cite journal |last1=Kulkarni |first1=SK |last2=Bhutani |first2=AK |last3=Bishnoi |first3=M. |title=Antidepressant activity of curcumin: involvement of serotonin and dopamine system. |journal=Psychopharmacology |date=3 September 2008 |volume=201 |issue=3 |pages=435–442 |doi=10.1007/s00213-008-1300-y |pmid=18766332 }}</ref><ref>{{cite journal |last1=Kulkarni |first1=S. K. |last2=Dhir |first2=A. |title=An Overview of Curcumin in Neurological Disorders |journal=Indian Journal of Pharmaceutical Sciences |date=March 2010 |volume=72 |issue=2 |pages=149–154 |pmc=2929771 |doi=10.4103/0250-474X.65012 |pmid=20838516}}</ref> (selectivity for MAO-A is disputed<ref>{{cite web |title=Curcumin and the MAO Inhibitor "Cheese Effect" from Tyramine Triggered Hypertension |url=https://emediahealth.com/2012/01/17/curcumin-and-the-mao-inhibitor-cheese-effect-from-tyramine-triggered-hypertension/ |website=EmediaHealth |date=17 January 2012 |accessdate=28 March 2017 |deadurl=no |archiveurl=https://web.archive.org/web/20170330014040/https://emediahealth.com/2012/01/17/curcumin-and-the-mao-inhibitor-cheese-effect-from-tyramine-triggered-hypertension/ |archivedate=30 March 2017 |df=dmy-all }}</ref>). Curcumin is commonly sold with piperine that enhances the effect of MAO inhibition. | ** Turmeric (''Curcuma longa''): Curcumin<ref>{{cite journal |last1=Kulkarni |first1=SK |last2=Bhutani |first2=AK |last3=Bishnoi |first3=M. |title=Antidepressant activity of curcumin: involvement of serotonin and dopamine system. |journal=Psychopharmacology |date=3 September 2008 |volume=201 |issue=3 |pages=435–442 |doi=10.1007/s00213-008-1300-y |pmid=18766332 }}</ref><ref>{{cite journal |last1=Kulkarni |first1=S. K. |last2=Dhir |first2=A. |title=An Overview of Curcumin in Neurological Disorders |journal=Indian Journal of Pharmaceutical Sciences |date=March 2010 |volume=72 |issue=2 |pages=149–154 |pmc=2929771 |doi=10.4103/0250-474X.65012 |pmid=20838516}}</ref> (selectivity for MAO-A is disputed<ref>{{cite web |title=Curcumin and the MAO Inhibitor "Cheese Effect" from Tyramine Triggered Hypertension |url=https://emediahealth.com/2012/01/17/curcumin-and-the-mao-inhibitor-cheese-effect-from-tyramine-triggered-hypertension/ |website=EmediaHealth |date=17 January 2012 |accessdate=28 March 2017 |deadurl=no |archiveurl=https://web.archive.org/web/20170330014040/https://emediahealth.com/2012/01/17/curcumin-and-the-mao-inhibitor-cheese-effect-from-tyramine-triggered-hypertension/ |archivedate=30 March 2017 |df=dmy-all }}</ref>). Curcumin is commonly sold with piperine that enhances the effect of MAO inhibition. | ||
* Psychoactive substances | * Psychoactive substances | ||
** [[AMT]]<ref>Studies of Monoamine Oxidase and Semicarbazide-Sensitive Amine Oxidase II. Inhibition by α-Methylated Substrate-Analogue Monoamines, α-Methyltryptamine, α-Methylbenzylamine and Two Enantiomers of α-Methylbenzylamine | https://www.jstage.jst.go.jp/article/jphs1951/41/2/41_2_191/_article</ref> | |||
** [[5-IT]]<ref>{{cite journal |url=http://onlinelibrary.wiley.com/doi/10.1002/dta.1530/abstract |title=5-(2-Aminopropyl)indole (5-IT): a psychoactive substance used for recreational purposes is an inhibitor of human monoamine oxidase (MAO) |author =Tomás Herraiz |author2 =Simon D. Brandt |journal=Drug Testing and Analysis |date=July–August 2014 |volume=6 |issue=7–8 |pages=607–613 |doi=10.1002/dta.1530 |pmid=24115740}}</ref> | ** [[5-IT]]<ref>{{cite journal |url=http://onlinelibrary.wiley.com/doi/10.1002/dta.1530/abstract |title=5-(2-Aminopropyl)indole (5-IT): a psychoactive substance used for recreational purposes is an inhibitor of human monoamine oxidase (MAO) |author =Tomás Herraiz |author2 =Simon D. Brandt |journal=Drug Testing and Analysis |date=July–August 2014 |volume=6 |issue=7–8 |pages=607–613 |doi=10.1002/dta.1530 |pmid=24115740}}</ref> | ||